Sort
35,931 grants matching “parkinsons”
Longitudinal Imaging Biomarkers of Disease Progression in DLB
$1,423,921Kejal Kantarci · Mayo Clinic Rochester · U01 · FY2019 · NS
Molecular Chaperones and DNA Replication
$1,423,861Sue H Wickner · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Molecular Chaperones and DNA Replication
$1,422,832Sue McKenney · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells
$1,422,765Leslie Michels Thompson · University Of California-Irvine · U54 · FY2019 · NS
Bacterial disruption of neuroimmune pathways in a transparent brain
$1,422,000Cressida Arianna Madigan · University Of California, San Diego · DP2 · FY2021 · NS
Chemical Control of Misfolded Protein Fate
$1,422,000Fleur Marcia Ferguson · University Of California, San Diego · DP2 · FY2022 · NS
Decode Mitochondrial Morphology Dynamics to Predict Cell Fate Decisions
$1,422,000Johannes Schoeneberg · University Of California, San Diego · DP2 · FY2022 · GM
NHGRI Advanced Imaging & Analysis Core
$1,421,824Stephen Wincovitch · National Human Genome Research Institute · ZIC · FY2024 · HG
Molecular Etiology of Early Onset Torsion Dystonia
$1,421,795Massachusetts General Hospital · P01 · FY2004 · NS
Biomedical Image Analysis and Informatics
$1,421,478Matthew McAuliffe · Center For Information Technology · ZIA · FY2020 · CT
Whole blood filter paper assay for Alzheimers Disease
$1,421,226Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2023 · AG
Tools for Mapping Mammalian Nervous System Connections with Modified Rabies Virus
$1,420,167Edward M Callaway · Salk Institute For Biological Studies · RC2 · FY2010 · NS
IN VIVO PIB PET AMYLOID IMAGING: NORMALS, MCI & DEMENTIA
$1,420,069William E Klunk · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · AG
Simplified, Scalable 24-hour adaptive deep brain stimulation for Parkinsonâs disease
$1,419,954Philip A Starr · University Of California, San Francisco · UG3 · FY2025 · NS
Development of a novel, regenerative therapy to reverse synapse loss in Alzheimer's Disease
$1,419,610Peter W Vanderklish · Spinogenix, Inc. · R44 · FY2023 · AG
The cholinergic system during normal and pathological aging
$1,419,179Lorna Role · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Clinical Coordinating Center for the Acute to Chronic Pain Signatures Program
$1,417,940Kathleen A Sluka · University Of Iowa · U24 · FY2021 · NS
A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)
$1,417,321Charbel Moussa · Georgetown University · R01 · FY2019 · AG
A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)
$1,417,321Charbel Moussa · Georgetown University · R01 · FY2022 · AG
A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)
$1,417,321Charbel Moussa · Georgetown University · R01 · FY2020 · AG
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
$1,417,153Jie Shen · Brigham And Women'S Hospital · P50 · FY2016 · NS
An In Vivo/In Vitro 2-Photon Uncaging/Imaging Microscope
$1,415,803Martha C Constantine-Paton · Massachusetts Institute Of Technology · S10 · FY2010 · RR
Immunogenetic Determinants of Disease Risk in Neurological Disease
$1,414,582Jorge R. Oksenberg · University Of California, San Francisco · U19 · FY2019 · NS
Dementia with Lewy Bodies Consortium
$1,414,297James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · U01 · FY2018 · NS
Udall Parkinson's Disease Research Center at Emory University
$1,414,199Thomas N. Wichmann · Emory University · P50 · FY2016 · NS